Global Recombinant Protein Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Recombinant Protein Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Protein Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Protein Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Recombinant Protein Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Protein Drugs market, reaching US$ million by the year 2028. As for the Europe Recombinant Protein Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Protein Drugs players cover Novo Nordisk, Amgen, Sanofi, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Recombinant Protein Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Protein Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Protein Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Recombinant Protein Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Protein Drugs market, reaching US$ million by the year 2028. As for the Europe Recombinant Protein Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Protein Drugs players cover Novo Nordisk, Amgen, Sanofi, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Recombinant DNA
- Recombinant RNA
- Pharmaceutical Industry
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Amgen
- Sanofi
- Eli Lilly
- Merck Serono
- Ortho Biotech
- Roche
- Kyowa Hakko Kirin
- Pharmingen
- Abcam
- GenSci
- SL PHARM
- Dongbao Pharm
- Ankebio
- NCPC
- Heng Rui
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Protein Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Protein Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Protein Drugs by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Protein Drugs Segment by Type
2.2.1 Recombinant DNA
2.2.2 Recombinant RNA
2.3 Recombinant Protein Drugs Sales by Type
2.3.1 Global Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Protein Drugs Sale Price by Type (2017-2022)
2.4 Recombinant Protein Drugs Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Others
2.5 Recombinant Protein Drugs Sales by Application
2.5.1 Global Recombinant Protein Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Protein Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Protein Drugs Sale Price by Application (2017-2022)
3 GLOBAL RECOMBINANT PROTEIN DRUGS BY COMPANY
3.1 Global Recombinant Protein Drugs Breakdown Data by Company
3.1.1 Global Recombinant Protein Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Protein Drugs Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Protein Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Protein Drugs Revenue by Company (2020-2022)
3.2.2 Global Recombinant Protein Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Protein Drugs Sale Price by Company
3.4 Key Manufacturers Recombinant Protein Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Protein Drugs Product Location Distribution
3.4.2 Players Recombinant Protein Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT PROTEIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Protein Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Protein Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Protein Drugs Annual Revenue by Geographic Region
4.2 World Historic Recombinant Protein Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Protein Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Protein Drugs Annual Revenue by Country/Region
4.3 Americas Recombinant Protein Drugs Sales Growth
4.4 APAC Recombinant Protein Drugs Sales Growth
4.5 Europe Recombinant Protein Drugs Sales Growth
4.6 Middle East & Africa Recombinant Protein Drugs Sales Growth
5 AMERICAS
5.1 Americas Recombinant Protein Drugs Sales by Country
5.1.1 Americas Recombinant Protein Drugs Sales by Country (2017-2022)
5.1.2 Americas Recombinant Protein Drugs Revenue by Country (2017-2022)
5.2 Americas Recombinant Protein Drugs Sales by Type
5.3 Americas Recombinant Protein Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Drugs Sales by Region
6.1.1 APAC Recombinant Protein Drugs Sales by Region (2017-2022)
6.1.2 APAC Recombinant Protein Drugs Revenue by Region (2017-2022)
6.2 APAC Recombinant Protein Drugs Sales by Type
6.3 APAC Recombinant Protein Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Protein Drugs by Country
7.1.1 Europe Recombinant Protein Drugs Sales by Country (2017-2022)
7.1.2 Europe Recombinant Protein Drugs Revenue by Country (2017-2022)
7.2 Europe Recombinant Protein Drugs Sales by Type
7.3 Europe Recombinant Protein Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Protein Drugs by Country
8.1.1 Middle East & Africa Recombinant Protein Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Protein Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Protein Drugs Sales by Type
8.3 Middle East & Africa Recombinant Protein Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
10.3 Manufacturing Process Analysis of Recombinant Protein Drugs
10.4 Industry Chain Structure of Recombinant Protein Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Protein Drugs Distributors
11.3 Recombinant Protein Drugs Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT PROTEIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Recombinant Protein Drugs Market Size Forecast by Region
12.1.1 Global Recombinant Protein Drugs Forecast by Region (2023-2028)
12.1.2 Global Recombinant Protein Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Protein Drugs Forecast by Type
12.7 Global Recombinant Protein Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Recombinant Protein Drugs Product Offered
13.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Recombinant Protein Drugs Product Offered
13.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Recombinant Protein Drugs Product Offered
13.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Recombinant Protein Drugs Product Offered
13.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Merck Serono
13.5.1 Merck Serono Company Information
13.5.2 Merck Serono Recombinant Protein Drugs Product Offered
13.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Serono Main Business Overview
13.5.5 Merck Serono Latest Developments
13.6 Ortho Biotech
13.6.1 Ortho Biotech Company Information
13.6.2 Ortho Biotech Recombinant Protein Drugs Product Offered
13.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ortho Biotech Main Business Overview
13.6.5 Ortho Biotech Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Recombinant Protein Drugs Product Offered
13.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Kyowa Hakko Kirin
13.8.1 Kyowa Hakko Kirin Company Information
13.8.2 Kyowa Hakko Kirin Recombinant Protein Drugs Product Offered
13.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kyowa Hakko Kirin Main Business Overview
13.8.5 Kyowa Hakko Kirin Latest Developments
13.9 Pharmingen
13.9.1 Pharmingen Company Information
13.9.2 Pharmingen Recombinant Protein Drugs Product Offered
13.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pharmingen Main Business Overview
13.9.5 Pharmingen Latest Developments
13.10 Abcam
13.10.1 Abcam Company Information
13.10.2 Abcam Recombinant Protein Drugs Product Offered
13.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Abcam Main Business Overview
13.10.5 Abcam Latest Developments
13.11 GenSci
13.11.1 GenSci Company Information
13.11.2 GenSci Recombinant Protein Drugs Product Offered
13.11.3 GenSci Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GenSci Main Business Overview
13.11.5 GenSci Latest Developments
13.12 SL PHARM
13.12.1 SL PHARM Company Information
13.12.2 SL PHARM Recombinant Protein Drugs Product Offered
13.12.3 SL PHARM Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SL PHARM Main Business Overview
13.12.5 SL PHARM Latest Developments
13.13 Dongbao Pharm
13.13.1 Dongbao Pharm Company Information
13.13.2 Dongbao Pharm Recombinant Protein Drugs Product Offered
13.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dongbao Pharm Main Business Overview
13.13.5 Dongbao Pharm Latest Developments
13.14 Ankebio
13.14.1 Ankebio Company Information
13.14.2 Ankebio Recombinant Protein Drugs Product Offered
13.14.3 Ankebio Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Ankebio Main Business Overview
13.14.5 Ankebio Latest Developments
13.15 NCPC
13.15.1 NCPC Company Information
13.15.2 NCPC Recombinant Protein Drugs Product Offered
13.15.3 NCPC Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 NCPC Main Business Overview
13.15.5 NCPC Latest Developments
13.16 Heng Rui
13.16.1 Heng Rui Company Information
13.16.2 Heng Rui Recombinant Protein Drugs Product Offered
13.16.3 Heng Rui Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Heng Rui Main Business Overview
13.16.5 Heng Rui Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Protein Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Protein Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Protein Drugs by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Protein Drugs Segment by Type
2.2.1 Recombinant DNA
2.2.2 Recombinant RNA
2.3 Recombinant Protein Drugs Sales by Type
2.3.1 Global Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Protein Drugs Sale Price by Type (2017-2022)
2.4 Recombinant Protein Drugs Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Others
2.5 Recombinant Protein Drugs Sales by Application
2.5.1 Global Recombinant Protein Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Protein Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Protein Drugs Sale Price by Application (2017-2022)
3 GLOBAL RECOMBINANT PROTEIN DRUGS BY COMPANY
3.1 Global Recombinant Protein Drugs Breakdown Data by Company
3.1.1 Global Recombinant Protein Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Protein Drugs Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Protein Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Protein Drugs Revenue by Company (2020-2022)
3.2.2 Global Recombinant Protein Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Protein Drugs Sale Price by Company
3.4 Key Manufacturers Recombinant Protein Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Protein Drugs Product Location Distribution
3.4.2 Players Recombinant Protein Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT PROTEIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Protein Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Protein Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Protein Drugs Annual Revenue by Geographic Region
4.2 World Historic Recombinant Protein Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Protein Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Protein Drugs Annual Revenue by Country/Region
4.3 Americas Recombinant Protein Drugs Sales Growth
4.4 APAC Recombinant Protein Drugs Sales Growth
4.5 Europe Recombinant Protein Drugs Sales Growth
4.6 Middle East & Africa Recombinant Protein Drugs Sales Growth
5 AMERICAS
5.1 Americas Recombinant Protein Drugs Sales by Country
5.1.1 Americas Recombinant Protein Drugs Sales by Country (2017-2022)
5.1.2 Americas Recombinant Protein Drugs Revenue by Country (2017-2022)
5.2 Americas Recombinant Protein Drugs Sales by Type
5.3 Americas Recombinant Protein Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Drugs Sales by Region
6.1.1 APAC Recombinant Protein Drugs Sales by Region (2017-2022)
6.1.2 APAC Recombinant Protein Drugs Revenue by Region (2017-2022)
6.2 APAC Recombinant Protein Drugs Sales by Type
6.3 APAC Recombinant Protein Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Protein Drugs by Country
7.1.1 Europe Recombinant Protein Drugs Sales by Country (2017-2022)
7.1.2 Europe Recombinant Protein Drugs Revenue by Country (2017-2022)
7.2 Europe Recombinant Protein Drugs Sales by Type
7.3 Europe Recombinant Protein Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Protein Drugs by Country
8.1.1 Middle East & Africa Recombinant Protein Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Protein Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Protein Drugs Sales by Type
8.3 Middle East & Africa Recombinant Protein Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
10.3 Manufacturing Process Analysis of Recombinant Protein Drugs
10.4 Industry Chain Structure of Recombinant Protein Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Protein Drugs Distributors
11.3 Recombinant Protein Drugs Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT PROTEIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Recombinant Protein Drugs Market Size Forecast by Region
12.1.1 Global Recombinant Protein Drugs Forecast by Region (2023-2028)
12.1.2 Global Recombinant Protein Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Protein Drugs Forecast by Type
12.7 Global Recombinant Protein Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Recombinant Protein Drugs Product Offered
13.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Recombinant Protein Drugs Product Offered
13.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Recombinant Protein Drugs Product Offered
13.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Recombinant Protein Drugs Product Offered
13.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Merck Serono
13.5.1 Merck Serono Company Information
13.5.2 Merck Serono Recombinant Protein Drugs Product Offered
13.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Serono Main Business Overview
13.5.5 Merck Serono Latest Developments
13.6 Ortho Biotech
13.6.1 Ortho Biotech Company Information
13.6.2 Ortho Biotech Recombinant Protein Drugs Product Offered
13.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ortho Biotech Main Business Overview
13.6.5 Ortho Biotech Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Recombinant Protein Drugs Product Offered
13.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Kyowa Hakko Kirin
13.8.1 Kyowa Hakko Kirin Company Information
13.8.2 Kyowa Hakko Kirin Recombinant Protein Drugs Product Offered
13.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kyowa Hakko Kirin Main Business Overview
13.8.5 Kyowa Hakko Kirin Latest Developments
13.9 Pharmingen
13.9.1 Pharmingen Company Information
13.9.2 Pharmingen Recombinant Protein Drugs Product Offered
13.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pharmingen Main Business Overview
13.9.5 Pharmingen Latest Developments
13.10 Abcam
13.10.1 Abcam Company Information
13.10.2 Abcam Recombinant Protein Drugs Product Offered
13.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Abcam Main Business Overview
13.10.5 Abcam Latest Developments
13.11 GenSci
13.11.1 GenSci Company Information
13.11.2 GenSci Recombinant Protein Drugs Product Offered
13.11.3 GenSci Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GenSci Main Business Overview
13.11.5 GenSci Latest Developments
13.12 SL PHARM
13.12.1 SL PHARM Company Information
13.12.2 SL PHARM Recombinant Protein Drugs Product Offered
13.12.3 SL PHARM Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SL PHARM Main Business Overview
13.12.5 SL PHARM Latest Developments
13.13 Dongbao Pharm
13.13.1 Dongbao Pharm Company Information
13.13.2 Dongbao Pharm Recombinant Protein Drugs Product Offered
13.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dongbao Pharm Main Business Overview
13.13.5 Dongbao Pharm Latest Developments
13.14 Ankebio
13.14.1 Ankebio Company Information
13.14.2 Ankebio Recombinant Protein Drugs Product Offered
13.14.3 Ankebio Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Ankebio Main Business Overview
13.14.5 Ankebio Latest Developments
13.15 NCPC
13.15.1 NCPC Company Information
13.15.2 NCPC Recombinant Protein Drugs Product Offered
13.15.3 NCPC Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 NCPC Main Business Overview
13.15.5 NCPC Latest Developments
13.16 Heng Rui
13.16.1 Heng Rui Company Information
13.16.2 Heng Rui Recombinant Protein Drugs Product Offered
13.16.3 Heng Rui Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Heng Rui Main Business Overview
13.16.5 Heng Rui Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Protein Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Protein Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant DNA
Table 4. Major Players of Recombinant RNA
Table 5. Global Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 6. Global Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Recombinant Protein Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Recombinant Protein Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Recombinant Protein Drugs Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 11. Global Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Recombinant Protein Drugs Revenue by Application (2017-2022)
Table 13. Global Recombinant Protein Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Recombinant Protein Drugs Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Recombinant Protein Drugs Sales by Company (2020-2022) & (K Doses)
Table 16. Global Recombinant Protein Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Recombinant Protein Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Recombinant Protein Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Recombinant Protein Drugs Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Recombinant Protein Drugs Producing Area Distribution and Sales Area
Table 21. Players Recombinant Protein Drugs Products Offered
Table 22. Recombinant Protein Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Protein Drugs Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Recombinant Protein Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Recombinant Protein Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Recombinant Protein Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Recombinant Protein Drugs Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Recombinant Protein Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Recombinant Protein Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Recombinant Protein Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Recombinant Protein Drugs Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Recombinant Protein Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Recombinant Protein Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Recombinant Protein Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Recombinant Protein Drugs
Table 66. Key Market Challenges & Risks of Recombinant Protein Drugs
Table 67. Key Industry Trends of Recombinant Protein Drugs
Table 68. Recombinant Protein Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Recombinant Protein Drugs Distributors List
Table 71. Recombinant Protein Drugs Customer List
Table 72. Global Recombinant Protein Drugs Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Recombinant Protein Drugs Sales Market Forecast by Region
Table 74. Global Recombinant Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Recombinant Protein Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Recombinant Protein Drugs Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Recombinant Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Recombinant Protein Drugs Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Recombinant Protein Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Recombinant Protein Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Recombinant Protein Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Protein Drugs Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Recombinant Protein Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Recombinant Protein Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Recombinant Protein Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Recombinant Protein Drugs Product Offered
Table 94. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. Amgen Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Amgen Recombinant Protein Drugs Product Offered
Table 99. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Sanofi Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Recombinant Protein Drugs Product Offered
Table 104. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Eli Lilly Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Eli Lilly Recombinant Protein Drugs Product Offered
Table 109. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Latest Developments
Table 112. Merck Serono Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck Serono Recombinant Protein Drugs Product Offered
Table 114. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Merck Serono Main Business
Table 116. Merck Serono Latest Developments
Table 117. Ortho Biotech Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Ortho Biotech Recombinant Protein Drugs Product Offered
Table 119. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Ortho Biotech Main Business
Table 121. Ortho Biotech Latest Developments
Table 122. Roche Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Roche Recombinant Protein Drugs Product Offered
Table 124. Roche Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. Roche Main Business
Table 126. Roche Latest Developments
Table 127. Kyowa Hakko Kirin Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Kyowa Hakko Kirin Recombinant Protein Drugs Product Offered
Table 129. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Kyowa Hakko Kirin Main Business
Table 131. Kyowa Hakko Kirin Latest Developments
Table 132. Pharmingen Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pharmingen Recombinant Protein Drugs Product Offered
Table 134. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Pharmingen Main Business
Table 136. Pharmingen Latest Developments
Table 137. Abcam Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Abcam Recombinant Protein Drugs Product Offered
Table 139. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. Abcam Main Business
Table 141. Abcam Latest Developments
Table 142. GenSci Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. GenSci Recombinant Protein Drugs Product Offered
Table 144. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. GenSci Main Business
Table 146. GenSci Latest Developments
Table 147. SL PHARM Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. SL PHARM Recombinant Protein Drugs Product Offered
Table 149. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 150. SL PHARM Main Business
Table 151. SL PHARM Latest Developments
Table 152. Dongbao Pharm Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Dongbao Pharm Recombinant Protein Drugs Product Offered
Table 154. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 155. Dongbao Pharm Main Business
Table 156. Dongbao Pharm Latest Developments
Table 157. Ankebio Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Ankebio Recombinant Protein Drugs Product Offered
Table 159. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 160. Ankebio Main Business
Table 161. Ankebio Latest Developments
Table 162. NCPC Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. NCPC Recombinant Protein Drugs Product Offered
Table 164. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 165. NCPC Main Business
Table 166. NCPC Latest Developments
Table 167. Heng Rui Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Heng Rui Recombinant Protein Drugs Product Offered
Table 169. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 170. Heng Rui Main Business
Table 171. Heng Rui Latest Developments
Table 1. Recombinant Protein Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Protein Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant DNA
Table 4. Major Players of Recombinant RNA
Table 5. Global Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 6. Global Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Recombinant Protein Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Recombinant Protein Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Recombinant Protein Drugs Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 11. Global Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Recombinant Protein Drugs Revenue by Application (2017-2022)
Table 13. Global Recombinant Protein Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Recombinant Protein Drugs Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Recombinant Protein Drugs Sales by Company (2020-2022) & (K Doses)
Table 16. Global Recombinant Protein Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Recombinant Protein Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Recombinant Protein Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Recombinant Protein Drugs Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Recombinant Protein Drugs Producing Area Distribution and Sales Area
Table 21. Players Recombinant Protein Drugs Products Offered
Table 22. Recombinant Protein Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Protein Drugs Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Recombinant Protein Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Recombinant Protein Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Recombinant Protein Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Recombinant Protein Drugs Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Recombinant Protein Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Recombinant Protein Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Recombinant Protein Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Recombinant Protein Drugs Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Recombinant Protein Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Recombinant Protein Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Recombinant Protein Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Recombinant Protein Drugs Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Recombinant Protein Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Recombinant Protein Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Protein Drugs Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Recombinant Protein Drugs Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Recombinant Protein Drugs
Table 66. Key Market Challenges & Risks of Recombinant Protein Drugs
Table 67. Key Industry Trends of Recombinant Protein Drugs
Table 68. Recombinant Protein Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Recombinant Protein Drugs Distributors List
Table 71. Recombinant Protein Drugs Customer List
Table 72. Global Recombinant Protein Drugs Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Recombinant Protein Drugs Sales Market Forecast by Region
Table 74. Global Recombinant Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Recombinant Protein Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Recombinant Protein Drugs Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Recombinant Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Recombinant Protein Drugs Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Recombinant Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Recombinant Protein Drugs Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Recombinant Protein Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Recombinant Protein Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Recombinant Protein Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Protein Drugs Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Recombinant Protein Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Recombinant Protein Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Recombinant Protein Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Recombinant Protein Drugs Product Offered
Table 94. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. Amgen Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Amgen Recombinant Protein Drugs Product Offered
Table 99. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Sanofi Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Recombinant Protein Drugs Product Offered
Table 104. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Eli Lilly Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Eli Lilly Recombinant Protein Drugs Product Offered
Table 109. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Latest Developments
Table 112. Merck Serono Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck Serono Recombinant Protein Drugs Product Offered
Table 114. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Merck Serono Main Business
Table 116. Merck Serono Latest Developments
Table 117. Ortho Biotech Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Ortho Biotech Recombinant Protein Drugs Product Offered
Table 119. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Ortho Biotech Main Business
Table 121. Ortho Biotech Latest Developments
Table 122. Roche Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Roche Recombinant Protein Drugs Product Offered
Table 124. Roche Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. Roche Main Business
Table 126. Roche Latest Developments
Table 127. Kyowa Hakko Kirin Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Kyowa Hakko Kirin Recombinant Protein Drugs Product Offered
Table 129. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Kyowa Hakko Kirin Main Business
Table 131. Kyowa Hakko Kirin Latest Developments
Table 132. Pharmingen Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Pharmingen Recombinant Protein Drugs Product Offered
Table 134. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Pharmingen Main Business
Table 136. Pharmingen Latest Developments
Table 137. Abcam Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Abcam Recombinant Protein Drugs Product Offered
Table 139. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. Abcam Main Business
Table 141. Abcam Latest Developments
Table 142. GenSci Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. GenSci Recombinant Protein Drugs Product Offered
Table 144. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. GenSci Main Business
Table 146. GenSci Latest Developments
Table 147. SL PHARM Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. SL PHARM Recombinant Protein Drugs Product Offered
Table 149. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 150. SL PHARM Main Business
Table 151. SL PHARM Latest Developments
Table 152. Dongbao Pharm Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Dongbao Pharm Recombinant Protein Drugs Product Offered
Table 154. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 155. Dongbao Pharm Main Business
Table 156. Dongbao Pharm Latest Developments
Table 157. Ankebio Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Ankebio Recombinant Protein Drugs Product Offered
Table 159. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 160. Ankebio Main Business
Table 161. Ankebio Latest Developments
Table 162. NCPC Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. NCPC Recombinant Protein Drugs Product Offered
Table 164. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 165. NCPC Main Business
Table 166. NCPC Latest Developments
Table 167. Heng Rui Basic Information, Recombinant Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Heng Rui Recombinant Protein Drugs Product Offered
Table 169. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 170. Heng Rui Main Business
Table 171. Heng Rui Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Protein Drugs
Figure 2. Recombinant Protein Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Protein Drugs Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Recombinant Protein Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Protein Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant DNA
Figure 10. Product Picture of Recombinant RNA
Figure 11. Global Recombinant Protein Drugs Sales Market Share by Type in 2021
Figure 12. Global Recombinant Protein Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Recombinant Protein Drugs Consumed in Pharmaceutical Industry
Figure 14. Global Recombinant Protein Drugs Market: Pharmaceutical Industry (2017-2022) & (K Doses)
Figure 15. Recombinant Protein Drugs Consumed in Others
Figure 16. Global Recombinant Protein Drugs Market: Others (2017-2022) & (K Doses)
Figure 17. Global Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Recombinant Protein Drugs Revenue Market Share by Application in 2021
Figure 19. Recombinant Protein Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Recombinant Protein Drugs Revenue Market Share by Company in 2021
Figure 21. Global Recombinant Protein Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Recombinant Protein Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Recombinant Protein Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Recombinant Protein Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 26. Americas Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 28. APAC Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 30. Europe Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 32. Middle East & Africa Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 34. Americas Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 35. United States Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Recombinant Protein Drugs Sales Market Share by Region in 2021
Figure 40. APAC Recombinant Protein Drugs Revenue Market Share by Regions in 2021
Figure 41. China Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 48. Europe Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2021
Figure 62. Manufacturing Process Analysis of Recombinant Protein Drugs
Figure 63. Industry Chain Structure of Recombinant Protein Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Recombinant Protein Drugs
Figure 2. Recombinant Protein Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Protein Drugs Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Recombinant Protein Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Protein Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant DNA
Figure 10. Product Picture of Recombinant RNA
Figure 11. Global Recombinant Protein Drugs Sales Market Share by Type in 2021
Figure 12. Global Recombinant Protein Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Recombinant Protein Drugs Consumed in Pharmaceutical Industry
Figure 14. Global Recombinant Protein Drugs Market: Pharmaceutical Industry (2017-2022) & (K Doses)
Figure 15. Recombinant Protein Drugs Consumed in Others
Figure 16. Global Recombinant Protein Drugs Market: Others (2017-2022) & (K Doses)
Figure 17. Global Recombinant Protein Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Recombinant Protein Drugs Revenue Market Share by Application in 2021
Figure 19. Recombinant Protein Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Recombinant Protein Drugs Revenue Market Share by Company in 2021
Figure 21. Global Recombinant Protein Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Recombinant Protein Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Recombinant Protein Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Recombinant Protein Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 26. Americas Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 28. APAC Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 30. Europe Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Recombinant Protein Drugs Sales 2017-2022 (K Doses)
Figure 32. Middle East & Africa Recombinant Protein Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 34. Americas Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 35. United States Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Recombinant Protein Drugs Sales Market Share by Region in 2021
Figure 40. APAC Recombinant Protein Drugs Revenue Market Share by Regions in 2021
Figure 41. China Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 48. Europe Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Recombinant Protein Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Recombinant Protein Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Recombinant Protein Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2021
Figure 62. Manufacturing Process Analysis of Recombinant Protein Drugs
Figure 63. Industry Chain Structure of Recombinant Protein Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
